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BACKGROUND AND PURPOSE: Although the hyperattenuated middle cerebral artery sign is known to
be related to acute infarction, the volume of clot associated with it is not known. We investigated
whether the presence or absence of hyperattenuated artery sign (HAS) on noncontrast CT (NCCT) can
predict the thrombus volume.
MATERIALS AND METHODS: We enrolled 90 consecutive patients with acute infarction who underwent
both 5- and 1.25-mm NCCT and CT angiography (CTA). HAS was determined on 5-mm NCCT
retrospectively. According to the location of thrombi, the patients were classified into ICA (ICA
terminus/ICA and others), M1 (M1/both M1 and M2), and M2 (M2) groups. Thrombus volumes were
measured by 1.25-mm NCCT and were compared between patients with and without HAS.
RESULTS: Occlusion of major arteries was seen on CTA in 78 patients. HAS was found in 46 patients
(59.0%). The mean thrombus volume was significantly larger in patients with HAS than in those
without except for the M2 group (ICA group: [n  14], 188.7  122.5 mm3 versus 39.4  12.1 mm3
[P  .022]; M1 group: [n  42], 128.1  119.2 versus 56.8  32.5 [P  .005]; M2 group: [n  22],
34.7  32.2 versus 20.0  20.0 [P  .18]). Thrombus volumes determined by receiver operating
characteristic curve analysis were 52.36 mm3 in the ICA group (sensitivity, 90.9%; specificity, 100%)
and 53.96 mm3 in the M1 group (sensitivity, 88.0%; specificity, 58.8%).
CONCLUSION: Thrombus volumes were significantly larger in patients with HAS than in those without
in ICA and M1 occlusions. The detection of HAS may provide an idea concerning rapid and dichoto-
mized estimation of thrombus volume, which may be helpful for treatment decisions in potential
candidates for thrombolysis.
Although hyperattenuated artery sign (HAS) on noncon-trast CT (NCCT) represents the presence of the thrombus
in acute ischemic stroke,1,2 many patients with the thrombus
do not show the HAS. In previous studies using NCCT with
5-mm thickness, it has been reported that the HAS presents
in 5%–50% of patients with the thrombus in the M1 segment
of the middle cerebral artery (MCA)3-5 and in approximately
15% with the thrombus in the M2 segment.5,6 The volume of
the thrombus may affect outcomes. Patients with HAS in the
M1 segment had more severe ischemia and poorer outcome
than those without.5,7 In addition, rapid estimation of the
thrombus volume and its locationmay be helpful in determin-
ing treatment techniques, particularly in candidates for
thrombolytic treatment.8 The volume of the thrombus, as well
as its location, can be one of the factors determining the pres-
ence ofHAS.However, the relationship between the thrombus
volume and the presence of HAS is unknown. This may be
partly due to difficulty in estimation of thrombus volume.
Recently, more sensitive detection of thrombus and mea-
surement of its volume in patients with acute ischemic stroke
became feasible by using thin-section NCCT.9,10 Therefore,
we hypothesized that the relationship between the thrombus
volume and the presence of HAS on conventional 5-mm CT
could be determined with measurement of thrombus volume
by using thin-section NCCT, and also the best threshold of
thrombus volume for predicting the presence ofHAS could be
determined. The purpose of this study was to investigate
whether the presence or absence of HAS can be used in the
prediction of thrombus volume.
Materials and Methods
Patients
Between June 2003 and March 2007, 90 consecutive patients (31
women, 59 men; mean age, 66.9 years) who presented with acute
MCA territory ischemic stroke within 6 hours of symptomonset were
enrolled in this study. All patients had acute infarction, which was
confirmed with follow-up diffusion-weighted imaging within 2 days
after presentation.
CT Acquisition and Effective Dose Estimation
All patients underwent both 5- and 1.25-mm NCCT (LightSpeed
Plus; GEHealthcare, Milwaukee,Wis), according to a predetermined
protocol. Conventional axial 5-mm NCCT was performed first with
the following parameters: 120 kVp; 250 mA; rotation time, 0.8 sec-
onds; FOV, 25 cm. Twenty-eight to 30 images were obtained per
examination according to the patient’s head size. Helical 1.25-mm
NCCT was obtained after 5-mm CT, with the following parameters:
120 kVp; 250 mA; rotation time, 0.8 second; pitch, 0.75; FOV, 25 cm;
matrix, 512 512; pixel size, 0.49 0.49mm. The scan was obtained
parallel to the plane of the inferior orbital rim to the basion and ended
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7.5 cm above it to reduce the radiation dose. All images of 1.25-mm
NCCTwere reconstructed at 0.6-mmthickness. Last, CT angiography
(CTA) was performed with the same parameters as those of helical
1.25-mm NCCT. Effective radiation dose was estimated by using the
ImPACT CT dose calculator, Version 0.99x (www.impactscan.org/
ctdosimetry; Impact Performance Assessment of CT, Bence Jones Of-
fices, St. George’sHospital, London,UK) and theNational Radiologic
Protection Board SR-250 datasets. The estimated effective radiation
doses of conventional axial 5-mm NCCT (30 images) and helical
1.25-mmNCCTwere 1.2 and 1.6 mSv, respectively. The institutional
review board approved this study.
Determination of HAS on NCCT
In a retrospectivemanner, a neuroradiologist assessed CTA images to
determine artery occlusion (internal carotid artery [ICA], M1, and
M2 segments of the MCA). A neurologist and another neuroradiolo-
gist who were not involved in assessment of CTA independently re-
viewed the 5-mm NCCT scans to find HAS. HAS was defined as a
hyperattenuated lesion compared with the attenuation of the con-
tralateral arteries and adjacent parenchyma and was determined sub-
jectively. The anterior cerebral artery was not evaluated for HAS. Dis-
agreements were settled by consensus. According to the location of
the thrombus (HAS), the patients were classified into the ICA (ICA
terminus/ICA and others), M1 (M1/bothM1 andM2), andM2 (M2)
groups.
Thrombus Volume Measurement
A neuroradiologist who was not involved in determination of the
presence of HAS measured thrombus volume on 0.6-mm NCCT.
All Digital Imaging and Communication in Medicine data of pa-
tients who showed a thrombus on 1.25-mm NCCT were trans-
ferred to commercial 3D software (Rapidia 2.8, Infinitt, Seoul,
Korea). All pixels were segmented with a threshold of 50–100 HU
to select the thrombus. We drew a region of interest around the
thrombus and performed 3D region growing. Region of interest
dilation to the margin of the thrombus was performed at a thresh-
old of 40–100 HU. We did not perform segmentation with a
threshold of 40–100 HU first, because normal brain parenchyma
could be selected with this threshold. Therefore, we chose a thresh-
old of 50–100 HU to select thrombus alone and subsequently di-
lated pixels to approximate the margin of the thrombus. The vol-
ume was calculated with the number of voxels (Fig 1).
Fig 1. A representative case showing the procedure of thrombus volume measurement. A, Maximum intensity projection images of thin-section noncontrast CT in a patient with occlusion
in both M1 and M2 segments on the right (arrows). B, All pixels are segmented with a threshold of 50–100 HU to select the thrombus (azure areas). After selecting the function of 3D
region growing, we drew a region of interest around the thrombus on an axial image and then automatically segmented the whole thrombus (indigo areas). Note that the thrombus does
not approximate the border of the probable thrombus. C, Pixel dilation with a single iteration for the segmented thrombus is performed at a threshold of 40–100 HU. The thrombus
approximates its border more than does the thrombus on B (indigo areas). D, The volume and mean Hounsfield unit of the thrombus are calculated. MinValue indicates minimal value;
MeanValue, mean value; MaxValue, maximal value.
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Data Analyses
We compared thrombus volumes between patients with and without
HAS by using the Mann-Whitney U test. Thrombus volumes were
also compared among the groups (ICA,M1, andM2 groups) by using
the Kruskal-Wallis one-way analysis of variance test, followed by a
post hoc test. Comparison of a National Institutes of Health Stroke
Scale (NIHSS) score between the groups was done by t test. The rela-
tionship between thrombus location and the presence or absence of
HASwas determined by the2 test. The thrombus volumes predicting
the presence of HAS were determined by receiver operating charac-
teristic (ROC) curve analysis. AP value of less than .05was considered
to indicate statistical significance. All the statistical analyses were per-
formed with statistical software (Statistical Package for the Social Sci-
ences, Version 12; SPSS, Chicago, Ill).
Results
Occlusion of major arteries (ICA terminus, M1, and M2) was
identified on CTA in 78 patients. HAS was found in 46
(59.0%) of 78 patients, 11 (78.6%) in the ICA group (n 14),
25 (59.5%) in the M1 group (n 42), and 10 (45.5%) in the
M2 group (n  22). Interobserver reliability was excellent in
the determination of HAS (  0.806). The mean thrombus
volume, which wasmeasured in 78 patients with an occlusion,
was significantly larger in patients with HAS than in those
without, except for those in theM2 group (Table 1, Fig 2). The
mean thrombus volume in the M2 group was significantly
smaller than those in ICA and M1 groups (P  .0001), but
there was no difference between the latter groups (Table 2).
The presence or absence ofHASwas not related to the location
of the thrombus (P .05) (Table 2). The thrombus volumes
for predictability of the presence of HAS by ROC curve anal-
ysis were 52.36mm3 in the ICA group (sensitivity, 90.9%; 95%
confidence interval [CI], 58.7–98.5; specificity, 100%; 95%CI,
30.5–100.0) and 53.96mm3 (sensitivity, 88.0%; 95%CI, 68.8–
97.3; specificity, 58.8%; 95% CI, 33.0–81.5) in the M1 group.
We compared the baseline NIHSS scores between patients
with HAS in the ICA or M1 (ICA or M1 group, n  36) and
those in the M2 (M2 group) or without HAS (n  54). The
mean NIHSS score was significantly higher in patients in the
former (16.06  5.1) than the latter groups (12.76  6.9)
(P  .01).
Discussion
HAS is an indicator of the presence of the thrombus in the
artery. The detection of HAS has been particularly useful in
patients with stroke during the hyperacute stage, duringwhich
the parenchymal CT changes are not obvious, by providing
information of potential targets for thrombolytic treatment
and diagnostic clues of infarction. This study showed that the
presence of HAS can provide additional information by indi-
cating the presence of a larger thrombus when these patients
were compared with patients without HAS.
Brain CT has usually been performedwith 5-mm thickness
in evaluating patientswith acute stroke. The ICA terminus and
MCA are nonlinear in course and are 5 mm in diameter.
Therefore, a small thrombus in them may not be identified
due to the partial volume effect. However, the partial volume
effect may be mitigated by thrombus size and arterial course.
This was particularly true in occlusion of the ICA terminus,
which had a larger diameter andmore vertical course than that
in the MCA in our study. The ICA terminus demonstrated a
higher probability of HAS than the MCA when thrombus was
present in it and had a very high predictability for the large
volume (more than approximately 53 mm3) when HAS was
present. Although this pattern was observed in the M1 group,
a considerable overlap in the thrombus volume was present
between patients with HAS and those without; this may be
explained by a higher probability of the partial volume effect in
the MCA.
Although intravenous (IV) recombinant tissue-type plas-
minogen activator (rtPA) treatment was a breakthrough for
the effective recanalization of the occluded artery in patients
with stroke, the recanalization rate following the treatment is
known to be low, in that the thrombus can be successfully
lysed in only approximately a quarter of patients treated with
IV rtPA.8 The recanalization rate is further decreased in the
occlusion of the proximal arteries (ICA terminus and MCA)8
due to their larger thrombus volumes.3,11 Rapid estimation of
the thrombus location and volume at the time of initial eval-
uation may be helpful in determining treatment technique in
Fig 2. Thrombus volume comparison according to the presence or absence of hyperdense
artery sign.
Table 1: Thrombus volumes in patients with and without HAS
ICA Group (n  14) M1 Group (n  42) M2 Group (n  22)
HAS ()
(n  11)
HAS (–)
(n  3) P*
HAS ()
(n  25)
HAS (–)
(n  17) P*
HAS ()
(n  10)
HAS (–)
(n  12) P*
Mean thrombus volume (mm3) 188.7 122.5 39.4 12.1 .022 128.1 119.2 56.8 32.5 .005 34.7 32.2 20.0 20.0 .18
Note:— indicates presence; – indicates absence.
* Mann-Whitney U test.
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candidates for thrombolysis. For example, in patients whose
thrombus is thought to be large and/or located in the large
artery, additional treatment with mechanical thrombectomy
or intra-arterial treatment for IV thrombolysismay be consid-
ered from the beginning.
This study has a few limitations. First, wemeasured throm-
bus volume by using thin-section NCCT but did not validate
this method. The volume of a pure red clot may be accurately
measured in vitro by using thin-section NCCT because of its
homogeneous nature. However, in vivo thrombus is hetero-
geneous in nature, precluding it from accurate measurement
of its volume. Second, though areas containing calcium must
have been excluded because the thrombus volume measure-
ment was performed at a threshold of 50–100 HU, very small
amounts of calcium might be included due to partial volume
effect, which may result in overestimation of the thrombus
size. Nevertheless, CT-based measurements may be used for
estimation of the thrombus volume because thin-sectionCT is
sensitive in the detection of the thrombus, whereas nomethod
for exact measurement of the thrombus volume in the human
brain arteries has been available, to our knowledge. Third, we
did not analyze the relationship between thrombus volume
and efficacy of fibrinolysis or clinical outcome due to different
treatment methods among the patients. For this purpose, a
further prospective study should be followed.
Conclusion
The thrombus volume was significantly larger in patients with
HAS than in those without HAS in ICA andM1 occlusion, but
not in those with M2 occlusion. Our data indicate that the
presence of HAS on conventional 5-mmNCCT not only sug-
gests the presence of thrombus but also may provide a simple
and dichotomized estimation of the thrombus volume in pa-
tients with ICA or M1 occlusion.
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